480
Participants
Start Date
May 29, 2025
Primary Completion Date
December 31, 2028
Study Completion Date
July 31, 2029
AK112
AK112 20mg/kg, intravenous \[IV\]),Q3W
Placebo
Placebo, intravenous \[IV\]),Q3W
Beijing Cancer Hospital, Beijing
The First Medical Center of Chinese PLA General Hospital, Beijing
Beijing Chest Hospital, Beijing
Jilin Cancer Hospital, Changchun
Harbin Medical University Cancer Hospital, Harbin
The Second Affiliated Hospital of Harbin Medical University, Harbin
Shanghai Chest Hospital, Shanghai
Shanghai Pulmonary Hospital, Shanghai
Xuzhou Municipal Hospital, Xuzhou
Shandong Provincial Hospital, Jinan
Shandong Cancer Hospital, Jinan
Qingdao Central Hospital of Health and Rehabilitation Sciences University, Qingdao
Linyi People's Hospital, Linyi
Zaozhuang Municipal Hospital, Zaozhuang
Shanxi Cancer Hospital, Taiyuan
Tianjin Cancer Hospital, Tianjin
Taizhou Hospital of Zhejiang Province, Taizhou
The First Affiliated Hospital of Wenzhou Medical University, Wenzhou
The First Affiliated Hospital of Nanchang University, Nanchang
The First Affiliated Hospital of Gannan Medical University, Gannan
Fujian Cancer Hospital, Fuzhou
Zhangzhou Municipal Hospital of Fujian Province, Zhangzhou
Longyan First Hospital, Longyan
Hunan Cancer Hospital, Changsha
Hunan Cancer Hospital, Changsha
Jingzhou First People's Hospital, Jingzhou
Henan Cancer Hospital, Zhengzhou
The First Affiliated Hospital of Xinxiang Medical University, Xinxiang
Anyang Cancer Hospital, Anyang
Jiangmen Central Hospital, Jiangmen
Affiliated Cancer Hospital of Guangxi Medical University, Nanning
The First Affiliated Hospital of Guangxi Medical University, Nanning
Liuzhou People's Hospital, Liuzhou
The Second Affiliated Hospital of Zunyi Medical University, Zunyi
Sichuan People's Hospital, Chengdu
Mianyang Central Hospital, Mianyang
Yunnan Cancer Hospital, Kunming
Yunnan Cancer Hospital, Kunming
Qujing First People's Hospital, Qujing
Ningxia Medical University General Hospital, Yinchuan
The Fourth Hospital of Hebei Medical University, Shijiazhuang
Tangshan People's Hospital, Tangshan
Lead Sponsor
Akeso
INDUSTRY